Adcock Ingram Integrated Report 2016

40 / 182

OPERATIONAL REVIEW
PRESCRIPTION
NUMBER OF EMPLOYEES
186SALES, MARKETING
AND ADMINISTRATION 375FACTORY
MANUFACTURING
The Prescription division sells and markets medicines which are prescribed
by medical practitioners and dispensed against a prescription. The division
markets a range of quality and affordable generic medicines, including a
portfolio of anti-retroviral medicines.
The division enjoys the third position1 in the market based on value and the
second position based on volume and has a 8.8% share of prescriptions2 .
Accreditations
South Africa (MCC)
Ghana (FDB)
Botswana (DRU)
Malawi (PMPB)
Kenya (PPB)
Zimbabwe (MCA)
PIC/S
Wadeville
Capacity per annum
Liquids
6 million litres
Creams/Ointments
500 tonnes
Tablets and capsules
2 billion
1 IMS MAT June 2016, including MNC
2 Impact Rx June 2016, including MNC
Ashley Pearce
Managing
Director
Nick Ford
Financial
Director
Value market share1
6,8%
Volume market
share 1
11,5%
TURNOVER
R1 831
MILLION
(2015: R1 813m)
OUR PERFORMANCE (continued)
36 | Integrated Report 2016